A Study of TXN10128 in Subjects With Solid Tumors

NCT05978492 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced (Unresectable) or Metastatic Solid Tumors

Interventions

DRUG: TXN10128
DRUG: Irinotecan
DRUG: Paclitaxel

Sponsor

Txinno Bioscience Inc.